Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Antidepressant and anxiolytic effects of selective 5-HT6 receptor agonists in rats.

Carr GV, Schechter LE, Lucki I.

Psychopharmacology (Berl). 2011 Feb;213(2-3):499-507. doi: 10.1007/s00213-010-1798-7. Epub 2010 Mar 9.

PMID:
20217056
2.

The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration.

Nikiforuk A, Kos T, Wesołowska A.

Psychopharmacology (Berl). 2011 Oct;217(3):411-8. doi: 10.1007/s00213-011-2297-1. Epub 2011 Apr 16.

PMID:
21499701
3.

5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.

Eur Neuropsychopharmacol. 2004 Dec;14(6):487-95.

PMID:
15589388
4.

Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors.

Martínez-Mota L, Estrada-Camarena E, López-Rubalcava C.

Psychopharmacology (Berl). 2002 Dec;165(1):60-6. Epub 2002 Oct 23.

PMID:
12474119
5.

Potential role of the 5-HT6 receptor in depression and anxiety: an overview of preclinical data.

Wesołowska A.

Pharmacol Rep. 2010 Jul-Aug;62(4):564-77. Review.

PMID:
20884998
6.

Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.

Zhang H, Wang W, Jiang Z, Shang J, Zhang L.

Arzneimittelforschung. 2010;60(3):109-15. doi: 10.1055/s-0031-1296258.

PMID:
20422941
7.

F 11440, a potent, selective, high efficacy 5-HT1A receptor agonist with marked anxiolytic and antidepressant potential.

Koek W, Patoiseau JF, Assié MB, Cosi C, Kleven MS, Dupont-Passelaigue E, Carilla-Durand E, Palmier C, Valentin JP, John G, Pauwels PJ, Tarayre JP, Colpaert FC.

J Pharmacol Exp Ther. 1998 Oct;287(1):266-83.

PMID:
9765347
8.

Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.

Jastrzębska-Więsek M, Siwek A, Partyka A, Kubacka M, Mogilski S, Wasik A, Kołaczkowski M, Wesołowska A.

Neuropharmacology. 2014 Oct;85:253-62. doi: 10.1016/j.neuropharm.2014.05.036. Epub 2014 Jun 4.

PMID:
24905144
9.

Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.

Kassai F, Schlumberger C, Kedves R, Pietraszek M, Jatzke C, Lendvai B, Gyertyán I, Danysz W.

Behav Pharmacol. 2012 Aug;23(4):397-406. doi: 10.1097/FBP.0b013e3283565248.

PMID:
22785385
10.

The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Carr GV, Lucki I.

Psychopharmacology (Berl). 2011 Feb;213(2-3):265-87. doi: 10.1007/s00213-010-2097-z. Epub 2010 Nov 24. Review.

PMID:
21107537
11.

Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.

Wesołowska A, Nikiforuk A.

Neuropharmacology. 2007 Apr;52(5):1274-83. Epub 2007 Jan 20.

PMID:
17320917
12.

Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.

Briones-Aranda A, López-Rubalcava C, Picazo O.

Psychopharmacology (Berl). 2002 Jul;162(2):147-55. Epub 2002 May 15.

PMID:
12110992
13.

Serotonergic receptor mechanisms underlying antidepressant-like action in the progesterone withdrawal model of hormonally induced depression in rats.

Li Y, Raaby KF, Sánchez C, Gulinello M.

Behav Brain Res. 2013 Nov 1;256:520-8. doi: 10.1016/j.bbr.2013.09.002. Epub 2013 Sep 7.

PMID:
24016840
14.

Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test.

Cryan JF, Valentino RJ, Lucki I.

Neurosci Biobehav Rev. 2005;29(4-5):547-69. Review.

PMID:
15893822
15.

Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice.

Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I.

Psychopharmacology (Berl). 2015 Mar;232(5):907-15. doi: 10.1007/s00213-014-3723-y. Epub 2014 Sep 3.

PMID:
25178815
16.

Anxiolytic-like profiles of histamine H3 receptor agonists in animal models of anxiety: a comparative study with antidepressants and benzodiazepine anxiolytic.

Yokoyama F, Yamauchi M, Oyama M, Okuma K, Onozawa K, Nagayama T, Shinei R, Ishikawa M, Sato Y, Kakui N.

Psychopharmacology (Berl). 2009 Aug;205(2):177-87. doi: 10.1007/s00213-009-1528-1. Epub 2009 Apr 9.

PMID:
19357839
17.

Participation of the 5-HT1A receptor in the antidepressant-like effect of estrogens in the forced swimming test.

Estrada-Camarena E, Fernández-Guasti A, López-Rubalcava C.

Neuropsychopharmacology. 2006 Feb;31(2):247-55.

PMID:
16012533
18.

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL.

Psychopharmacology (Berl). 2007 Jun;192(2):159-70. Epub 2007 Feb 13.

PMID:
17297636
19.

Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.

Andreasen JT, Fitzpatrick CM, Larsen M, Skovgaard L, Nielsen SD, Clausen RP, Troelsen K, Pickering DS.

Brain Res. 2015 Mar 19;1601:117-26. doi: 10.1016/j.brainres.2015.01.001. Epub 2015 Jan 8.

PMID:
25578259
20.

Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment.

Costa CA, Cury TC, Cassettari BO, Takahira RK, Flório JC, Costa M.

BMC Complement Altern Med. 2013 Feb 23;13:42. doi: 10.1186/1472-6882-13-42.

PMID:
23432968
Items per page

Supplemental Content

Write to the Help Desk